Research programme: anti-ED-B fusion proteins - Philogen/Bayer HealthCareAlternative Names: Immunoconjugates - Bayer Schering Pharma/Philogen
Latest Information Update: 28 Mar 2011
At a glance
- Originator Philogen
- Class Antibodies; Proteins
- Mechanism of Action Angiogenesis inhibitors; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Solid tumours